1. Deraco M., Santoro N., Carraro O., Inglese M.G., Rebuffoni G., Guadagni S., Carlier Somers D., Vaglini M.: Peritoneal Carcinomatosis: Features of dissemination. Review. Tumori 1999; Vol. 85 N. 1: 1-5.
2. Sugarbaker PH.: Carcinomatosis from gastrointestinal cancer. Ann Med. 2004;36(1):9-22.
3. Sugarbaker PH.: Managing the peritoneal surface component of gastrointestinal cancer. Part 1. Patterns of dissemination and treatment options. Oncology (Huntingt). 2004 Jan;18(1):51-9.
4. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, Francois Y, Vignal J, Gilly FN. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000 Jan 15;88(2):358-63.
5. Markman M, Kelsen D: Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. J Cancer Res Clin Oncol 118:547-550, 1992.
6. Dedrick RL, Zaharko DS, Bender RA, Bleyer WA, Lutz RJ. Pharmacokinetic considerations on resistance to anticancer drugs. Cancer Chemother Rep. 1975 Jul-Aug;59(4):795-804.
7. Alberts DS, Liu PY, Hannigan EV, O'Toole R, Williams SD, Young JA, Franklin EW, Clarke-Pearson DL, Malviya VK, DuBeshter B. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med. 1996 Dec 26;335(26):1950-5.
8. Markman M, Bundy BN, Alberts DS, Fowler JM, Clark-Pearson DL, Carson LF, Wadler S, Sickel J. Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol. 2001 Feb 15;19(4):1001-7.
9. Los G, McVie JG. Experimental and clinical status of intraperitoneal chemotherapy. Eur J Cancer 1990; 26: 755-62.
10. Markman M.: Intraperitoneal Chemotherapy. Semin. Oncol., 18: 248-254, 1991.
11. Glehen O, Stuart OA, Mohamed F, Sugarbaker PH.: Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model. Cancer Chemother Pharmacol. 2004 Jul;54(1):79-84. Epub 2004 Mar 26.
12. Cavaliere F, Di Filippo F, Botti C, Cosimelli M, Giannarelli D, Aloe L, Arcuri E, Aromatario C, Consolo S, Callopoli A, Laurenzi L, Tedesco M, Di Angelo P, Giunta S, Cavaliere R. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis. Eur J Surg Oncol. 2000 Aug;26(5):486-91
13. Engelhardt R: Hyperthermia and drugs. Recent Results Cancer. Res., 104:136-203, 1987.
14. Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC: Enhancement by hyperthermia of the in vitro citotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res, 41:1096-1099, 1981.
15. Hettinga JVE, Lemstra W, Meijer C, Dam WA, Uges DRA, Konings AWT, Vries EGE, Kampinge H: Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumor cells. Br J Cancer, 75:1735-1743, 1997.
16. Bozzetti F, Vaglini M, Deraco M: Intraperitoneal hyperthermic chemotherapy in gastric cancer: rationale for a new approach. Tumori, 84:483-488, 1998.
17. Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K, Ciuchi S, Okui K, Miyoshi T, Arimizu N, et al. Intraperitoneal hyperthermic perfusion combined with surgery effective forgastric cancer patients with peritoneal seeding.Ann Surg. 1988 Jul;208(1):36-41.
18. Vaglini M, Deraco M, Pennacchioli E. Regional Chemotherapy for Solid Tumors. In: Surgical Oncology "Contemporary Principles and Practice" - Kirby I. Bland MD., John M. Daly MD., Constantine P. Karakousis.MD. PhD FACS. McGRAW-HILL Medical Publishing Division.
19. Sugarbaker P.H. Peritonectomy procedures. Annals of surgery, 221(1):29-42, 1995.
20. Sugarbaker PH. Laser-mode electrosurgery. Cancer Treat Res. 1996;82:375-85.
21. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, Steves MA, Sugarbaker PH. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999 Dec;6(8):790-6.
22. Salle B., Gilly F.N., Carry P.Y., Sayag A., Brachet A., Braillon G.: Intraperitoneal chemo-hyperthermia in the treatment of peritoneal carcinomatosis of ovarian origin. Initial cases, physiopathologic data. J. Gynecol. Obstet. Biol. Reprod., (Paris) 22: 369-371, 1993.
23. Deraco M., Vaglini M., Santinami M., Costagli V., Di Re F., Inglese M.G., Mascotti G., Persiani L., Santoro N., Sequeira C., Carlier-Somers D.: Razionale per un trattamento chemioipertermico della carcinosi peritoneale. Argomenti di Oncologia, 16: 149-159, 1995.
24. Elias D, Matsuhisa T, Sideris L, Liberale G, Drouard-Troalen L, Raynard B,Pocard M, Puizillou JM, Billard V, Bourget P, Ducreux M. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol. 2004 Oct;15(10):1558-65.
25. Deraco Marcello, Raspagliesi Francesco and Kusamura Shigeki. Management of peritoneal surface component of ovarian cancer. Surg Oncol Clin N Am. 2003 Jul;12(3):561-83.
26. Rossi C.R., Foletto M., Mocellin S., Pilati P., De S.M., Deraco M., Cavaliere F., Palatini P., Guasti F., Scalerta R., Lise M. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study. Cancer 2002: 15(94): 492-499.
27. Fujimoto S, Takahashi M, Kobayashi K, Kure M, Masaoka H, Ohkubo H, Isaka S, Shimazaki J. Combined treatment of pelvic exenterative surgery and intra-operative pelvic hyperthermochemotherapy for locally advanced rectosigmoid cancer: report of a case. Surg Today. 1993;23(12):1094-8.
28. Elias D, Bonnay M, Puizillou JM, Antoun S, Demirdjian S, El OA, Pignon JP, Drouard-Troalen L, Ouellet JF, Ducreux M. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol. 2002 Feb;13(2):267-72.
29. de Bree E, Rosing H, Beijnen JH, Romanos J, Michalakis J, Georgoulias V, Tsiftsis DD. Pharmacokinetic study of docetaxel in intraoperative hyperthermic i.p. chemotherapy for ovarian cancer. Anticancer Drugs. 2003 Feb;14(2):103-10.
30. Kusamura S., Deraco M., Baratti D., Inglese M:G:, Costanzo P., Favaro M., Manzi R., Gavazzi C. Cytoreductive Surgery followed by Intra Peritoneal Hyperthermic Perfusion in the treatment of peritoneal surface malignancies: Morbidity and Mortality with Closed Abdomen Technique. J. of Exp. Clin. Cancer Res. 2003 S Dec;22(4):.207-212
31. Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S,Trillet-Lenoir V, Sayag-Beaujard AC, Francois Y, Vignal J, Gilly FN. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003 Oct;10(8):863-9.
32. De Simone M, Barone R, Vaira M, Aghemo B, Mioli P, Franco C, Scuderi S, Costamagna D, Dei Poli M. Semi-closed hyperthermic-antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinosis. J Surg Oncol. 2003 Feb;82(2):138-40.
33. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, Steves MA, Sugarbaker PH. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999 Dec;6(8):790-6.
34. Vaglini M, Deraco M, Santinami M, Re F, Inglese MG, Manzi R, Persiani L, Santoro N, Sequeira C, Sala S, Somers DC, Stefanon B. Chemioipertermia intraperitoneale; tecnica chirurgica. Argomenti di Oncologia, 16: 161-167, 1995.
35. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, Steves MA, Sugarbaker PH. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999 Dec;6(8):790-6.
36. Rossi R.C., Pilati P.L., Mocellin S., Vaglini M., Deraco M., Lise M.: Carcinoma dell'ovaio: studio pilota sulla perfusione ipertermico-antiblastica intraperitoneale intraoperatoria. Tumori 1999; Vol. 85 N.3 Suppl. 1: 43-45.
37. Deraco M, Rossi CR, Pennacchioli E, Merson M, Carlier Somers D, Santoro N, Kusamura K and Vaglini M. Cytoreductive Surgery and Intra Peritoneal Perfusion in the treatment of recurrent epithelial ovarian cancer: a Phase II clinical Study". Tumori; 2001: Vol. 87: 120-126.
38. Deraco Marcello, De Simone Michele, Rossi Carlor Riccardo, Cavaliere Francesco, Difilippo Franco, Scuderi Stefano, Pilatti Pierluigi and Shigeki Kusamura. An Italian multicentric phase II study on Peritonectomy and Intra Peritoneal Hyperthermic Perfusion (IPHP) to treat patients with Peritoneal Mesothelioma. J. of Exp. Clin. Cancer Res.2003 S Dec;22(4):.41-45.
39. Deraco M., Casali P., Inglese M.G., Baratti D., Pennacchioli E., Bertulli R., Kusamura S. Peritoneal Mesothelioma treated by Induction Chemotherapy, Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion. J Surg Oncol. 2003 Jul;83(3):147-53.
40. Glehen O, Gilly FN, Sugarbaker PH: New perspectives in the management of colorectal cancer: what about peritoneal carcinomatosis? Scand J Surg 92:178-179, 2003.
41. Cavaliere F., Perri P., Rossi C.R., Pilati P.L., De Simone M., Vaira M., Deraco M., Aloe S., Di Filippo S.and Di Filippo F. Sitilo Experience on Peritoneal Carcinomatosis from Colorectal Cancer: Clinical Prognostic Features. J. Exp. Clin. Cancer Research S Dec;22(4):.29-33
42. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y, Cavaliere F, Quenet F, Gutman M, Tentes AA, Lorimier G, Bernard JL, Bereder JM, Porcheron J, Gomez-Portilla A, Shen P, Deraco M, Rat P: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004 Aug 15;22(16):3284-92
43. Elias D, Blot F, El Otmany A, et al: Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92:71-76, 2001.
44. Vic J. Verwaal, Serge van Ruth, Eelco de Bree, Gooike W. van Slooten, Harm van Tinteren, Henk Boot, Frans A.N. Zoetmulder: Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer.
Journal of Clinical Oncology, Vol 21, Issue 20 (October), 2003: 3737-3743.
45. Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol. 2004 Apr;11(4):393-8.
46. Deraco Marcello, De Simone Michele, Rossi Carlo Riccardo, Cavaliere Francesco, Difilippo Franco, Pilati Pierluigi and Shigeki Kusamura. An Italian multicentric phase II study on Peritonectomy and Intra Peritoneal Hyperthermic Perfusion (IPHP) to treat patients with Pseudomyxoma Peritonei. J. of Exp. Clin. Cancer Res. 2003 S Dec; 22(4):.35-39.
47. Mohamed F, Gething S, Haiba M, Brun EA, Sugarbaker PH: Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process. J Surg Oncol. 2004 Apr 1;86(1):10-5.
48. Sugarbaker PH, Yu W, Yonemura Y.: Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol. 2003;21(4):233-48.
49. Yu W, Whang I, Chung HY, Averbach A, Sugarbaker PH. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg. 2001 Aug;25(8):985-90.
50. Bozzetti F, Vaglini M, Deraco M. Intraperitoneal hyperthermic chemotherapy in gastric cancer: rationale for a new approach. Tumori. 1998 Jul-Aug;84(4):483-8.
51. Akiyama H, Yamaoka H, Tanaka K, Ishikawa T, Ichikawa Y, Wakasugi J, Nagashima Y, Shimada H. Continuous hyperthermic peritoneal perfusion for peritoneal dissemination of gastric cancer. Hepatogastroenterology. 1998 Nov-Dec;45(24):2079-86.
52.Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y, Cavaliere F, Quenet F, Gutman M, Tentes AA, Lorimier G, Bernard JL, Bereder JM, Porcheron J, Gomez-Portilla A, Shen P, Deraco M, Rat P. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004 Aug 15;22(16):3284-92.
53.Wei G, Fang GE, Bi JW, Shen XJ, Nie MM, Xue XC, Hua JD. [Efficacy of Intraoperative Hypotonic Peritoneal Chemo-hyperthermia Combined with Early Postoperative Intraperitoneal Chemotherapy on Gastric Cancer.] Ai Zheng. 2005 Apr;24(4):478-82. Chinese.
54.Hall JJ, Loggie BW, Shen P, Beamer S, Douglas Case L, McQuellon R, Geisinger KR, Levine EA. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg. 2004 May-Jun;8(4):454-63.
55. Glehen O, Schreiber V, Cotte E, Sayag-Beaujard AC, Osinsky D, Freyer G, Francois Y, Vignal J, Gilly FN. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg. 2004 Jan;139(1):20-6.
56.Akiyama H, Kunisaki C, Nomura M, Matsuda G, Otsuka Y, Ono H, Shimada H. [Effectiveness of continuous hyperthermic peritoneal perfusion for the peritoneal dissemination of gastric cancer] Gan To Kagaku Ryoho. 2002 Nov;29(12):2168-73. Japanese.
57. Kunisaki C, Shimada H, Nomura M, Akiyama H, Takahashi M, Matsuda G. Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer. Surgery. 2002 May;131(5):521-8.
58. Kim JY, Bae HS. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer. 2001;4(1):27-33.
59.Hall JJ, Loggie BW, Shen P, Beamer S, Douglas Case L, McQuellon R, Geisinger KR, Levine EA. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg. 2004 May-Jun;8(4):454-63.
60. Piso P, Dahlke MH, Loss M, Schlitt HJ. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer. World J Surg Oncol. 2004 Jun 28;2(1):21.
61. Ryu KS, Kim JH, Ko HS, Kim JW, Ahn WS, Park YG, Kim SJ, Lee JM. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol. 2004 Aug;94(2):325-32.
62.Deraco M, Rossi CR, Pennacchioli E, Guadagni S, Somers DC, Santoro N,Raspagliesi F, Kusamura S, Vaglini M. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study. Tumori. 2001 May-Jun;87(3):120-6.
63.Raspagliesi F, Deraco M, Rossi CR. Stage III / IV epithelial ovarian cancer with macroscopic residual disease after 1st line Chemotherapy: a multicentric prospective randomised study comparing loco regional approach + systemic chemotherapy vs systemic chemotherapy alone.